购物车
  • TargetMol
    您的购物车当前为空

Setipiprant

一键复制产品信息
Rating icon 很棒

纯度: 99.16%

货号 T3520Cas号 866460-33-5

别名 塞替匹仑, KYTH-105, ACT-129968

Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。

Setipiprant
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Setipiprant

一键复制产品信息
Rating icon 很棒

纯度: 99.16%

货号 T3520 别名 塞替匹仑, KYTH-105, ACT-129968Cas号 866460-33-5

Setipiprant (ACT-129968) 是一种口服的选择性 CRTH2 拮抗剂,IC50为6.0 nM。

规格价格库存数量
2 mg
¥ 132
现货
5 mg
¥ 198
现货
10 mg
¥ 278
现货
25 mg
¥ 446
现货
50 mg
¥ 693
现货
100 mg
¥ 1,090
现货
200 mg
¥ 1,560
待询
1 mL x 10 mM (in DMSO)
¥ 253
现货
库存状态实时更新,以官网显示为准,现货产品可直接加购物车下单
大包装 & 定制
加入购物车
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
选择批次:
纯度: 99.16%
联系我们 获取更多批次信息

产品介绍


Setipiprant AI Summary
Setipiprant exhibits prolonged elimination half-life in human and rat plasma, along with a favorable volume of distribution in Wistar rats. It demonstrates potent antagonist activity at the CRTH2 receptor with high selectivity over the DP1 receptor and significant protein binding in plasma. The compound shows promising oral bioavailability in both beagle dogs and Wistar rats, potent inhibition of CYP enzymes, various antagonist activities at different prostanoid receptors, and strong affinity for the CRTH2 receptor with a low IC50 value. Additionally, it has moderate intrinsic clearance in liver microsomes and hepatocytes, and satisfactory clearance rates in beagle dogs and Wistar rats. Furthermore, Setipiprant exhibits antiviral activity against SARS-CoV-2. It inhibits SARS-CoV-2 induced cytotoxicity of Caco-2 cells by 8.44% at a 10 µM concentration after 48 hours, and shows a slight inhibitory effect (-0.12%) on the cytotoxicity of VERO-6 cells under similar conditions. It also demonstrates inhibition of the SARS-CoV-2 3CL-Pro protease, with an observed effect of -7.312% at a 20 µM concentration. Despite these activities, the compound shows moderate potency (IC50 > 20,000 nM) in inhibiting virus-induced cytotoxic effects in VERO-6 cells. Setipiprant also shows inhibitory activity on the human HDAC6 enzyme, with 34.49% inhibition in an enzymatic assay using a commercial peptide substrate, though it showed -7.96% inhibition with a custom peptide substrate, suggesting a varied interaction dependent on the substrate used..
Note: Summary generated by AI. Data source: ChEMBL
生物活性
产品描述
Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of PGD2 to CRTH2, which are expressed on the surface of blood-borne cells, induces chemotaxis of Th2 cells, basophils, and eosinophils, and stimulates cytokine release from these cells.
靶点活性
DP1 (human):1290 nM, CRTH2:6.0 nM, EP2:2600 nM
别名塞替匹仑, KYTH-105, ACT-129968
化学信息
分子量402.42
分子式C24H19FN2O3
CAS No.866460-33-5
SmilesC(C(O)=O)N1C2=C(C=3C1=CC=C(F)C3)CN(C(=O)C=4C5=C(C=CC4)C=CC=C5)CC2
密度1.37 g/cm3 (Predicted)
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
溶解度信息
DMSO: 45 mg/mL (111.82 mM), Sonication is recommended.
体内实验配方
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.97 mM), Sonication is recommended.
请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.4850 mL12.4248 mL24.8497 mL124.2483 mL
5 mM0.4970 mL2.4850 mL4.9699 mL24.8497 mL
10 mM0.2485 mL1.2425 mL2.4850 mL12.4248 mL
20 mM0.1242 mL0.6212 mL1.2425 mL6.2124 mL
50 mM0.0497 mL0.2485 mL0.4970 mL2.4850 mL
100 mM0.0248 mL0.1242 mL0.2485 mL1.2425 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSOPEG300PEG400Tween 80SBE-β-CD玉米油等, 均可在TargetMol网站点击购买。
1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

Related Tags: buy Setipiprant | purchase Setipiprant | Setipiprant cost | order Setipiprant | Setipiprant chemical structure | Setipiprant formula | Setipiprant molecular weight